Position in IBRX
as of Mar 31, 2026
· filed Apr 27, 2026
Position Value
$3,014
New position
Shares Held
393
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Biotechnology
Healthcare · as of Mar 31, 2026NVWM, LLC holds $1,880,123 across 17 Biotechnology names. IBRX ranks #7 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
1,535 | $1,120,933 | |
| 2 | CYTK |
Cytokinetics Inc
|
9,217 | $607,491 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
128 | $98,897 | |
| 4 | ARQT |
Arcutis Biotherapeutics, Inc.
|
1,000 | $23,560 | |
| 5 | DFTX |
Definium Therapeutics, Inc.
|
416 | $7,862 | |
| 6 | VKTX |
Viking Therapeutics, Inc.
|
165 | $5,369 | |
| 7 | IBRX |
ImmunityBio, Inc.
This page
|
393 | $3,014 | |
| 8 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6 | $2,679 |
All Filings in IBRX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,014 | 393 | Shares | Sole | 2026-04-27 | |
| No filing history on record for this holder in this stock. | ||||||